Literature DB >> 32585155

Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.

Patrick J Mulcahey1, Sheng Tang2, Hajime Takano1, Alicia White1, Dayana R Davila Portillo1, Owen M Kane1, Eric D Marsh3, Zhaolan Zhou4, Douglas A Coulter5.   

Abstract

CDKL5 deficiency disorder (CDD) is a devastating neurodevelopmental disorder characterized by early-onset epilepsy, severe intellectual disability, cortical visual impairment and motor disabilities. Epilepsy is a central feature of CDD, with most patients having intractable seizures, but seizure frequency and severity can vary. Clinical reports demonstrate a diversity in seizure semiology and electrographic features, with no pattern diagnostic of CDD. Although animal models of CDD have shown evidence of hyperexcitability, spontaneous seizures have not been previously reported. Here, we present the first systematic study of spontaneous seizures in mouse models of CDD. Epileptic spasms, the most frequent and persistent seizure type in CDD patients, were recapitulated in two mouse models of CDD carrying heterozygous mutations, Cdkl5R59X and Cdkl5KO. Spasm-like events were present in a significant proportion of aged heterozygous female mice carrying either of the two Cdkl5 mutations with significant variability in seizure burden. Electrographically, spasms were most frequently associated with generalized slow-wave activity and tended to occur in clusters during sleep. CDD mice also showed interictal and background abnormalities, characterized by high-amplitude spiking and altered power in multiple frequency bands. These data demonstrate that aged female heterozygous Cdkl5 mice recapitulate multiple features of epilepsy in CDD and can serve to complement existing models of epileptic spasms in future mechanistic and translational studies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDKL5; Epilepsy; Epileptic spasms; Neurodevelopmental disorders

Mesh:

Substances:

Year:  2020        PMID: 32585155      PMCID: PMC8855336          DOI: 10.1016/j.expneurol.2020.113388

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.620


  37 in total

1.  Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.

Authors:  I-Ting Judy Wang; Megan Allen; Darren Goffin; Xinjian Zhu; Andrew H Fairless; Edward S Brodkin; Steve J Siegel; Eric D Marsh; Julie A Blendy; Zhaolan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

2.  Conditional Loss of Arx From the Developing Dorsal Telencephalon Results in Behavioral Phenotypes Resembling Mild Human ARX Mutations.

Authors:  Jacqueline C Simonet; C Nicole Sunnen; Jue Wu; Jeffrey A Golden; Eric D Marsh
Journal:  Cereb Cortex       Date:  2014-05-02       Impact factor: 5.357

3.  Precise characterization and quantification of infantile spasms.

Authors:  P Kellaway; R A Hrachovy; J D Frost; T Zion
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

4.  Key clinical features to identify girls with CDKL5 mutations.

Authors:  Nadia Bahi-Buisson; Juliette Nectoux; Haydeé Rosas-Vargas; Mathieu Milh; Nathalie Boddaert; Benoit Girard; Claude Cances; Dorothée Ville; Alexandra Afenjar; Marlène Rio; Delphine Héron; Marie Ange N'guyen Morel; Alexis Arzimanoglou; Christophe Philippe; Philippe Jonveaux; Jamel Chelly; Thierry Bienvenu
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

5.  GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.

Authors:  Matthew C Judson; Michael L Wallace; Michael S Sidorov; Alain C Burette; Bin Gu; Geeske M van Woerden; Ian F King; Ji Eun Han; Mark J Zylka; Ype Elgersma; Richard J Weinberg; Benjamin D Philpot
Journal:  Neuron       Date:  2016-03-24       Impact factor: 17.173

6.  Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.

Authors:  Eric Marsh; Carl Fulp; Ernest Gomez; Ilya Nasrallah; Jeremy Minarcik; Jyotsna Sudi; Susan L Christian; Grazia Mancini; Patricia Labosky; William Dobyns; Amy Brooks-Kayal; Jeffrey A Golden
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

7.  Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel.

Authors:  Kameryn M Butler; Cristina da Silva; John J Alexander; Madhuri Hegde; Andrew Escayg
Journal:  Pediatr Neurol       Date:  2017-09-06       Impact factor: 3.372

8.  The three stages of epilepsy in patients with CDKL5 mutations.

Authors:  Nadia Bahi-Buisson; Anna Kaminska; Nathalie Boddaert; Marlène Rio; Alexandra Afenjar; Marion Gérard; Fabienne Giuliano; Jacques Motte; Delphine Héron; Marie Ange N'guyen Morel; Perrine Plouin; Christian Richelme; Vincent des Portes; Olivier Dulac; Christophe Philippe; Catherine Chiron; Rima Nabbout; Thierry Bienvenu
Journal:  Epilepsia       Date:  2008-02-07       Impact factor: 5.864

9.  Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder.

Authors:  Sheng Tang; Barbara Terzic; I-Ting Judy Wang; Nicolas Sarmiento; Katherine Sizov; Yue Cui; Hajime Takano; Eric D Marsh; Zhaolan Zhou; Douglas A Coulter
Journal:  Nat Commun       Date:  2019-06-14       Impact factor: 14.919

10.  Mapping pathological phenotypes in a mouse model of CDKL5 disorder.

Authors:  Elena Amendola; Yang Zhan; Camilla Mattucci; Enrico Castroflorio; Eleonora Calcagno; Claudia Fuchs; Giuseppina Lonetti; Davide Silingardi; Alexei L Vyssotski; Dominika Farley; Elisabetta Ciani; Tommaso Pizzorusso; Maurizio Giustetto; Cornelius T Gross
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more
  10 in total

1.  Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.

Authors:  Barbara Terzic; M Felicia Davatolhagh; Yugong Ho; Sheng Tang; Yu-Ting Liu; Zijie Xia; Yue Cui; Marc V Fuccillo; Zhaolan Zhou
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

Review 2.  CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.

Authors:  William Hong; Isabel Haviland; Elia Pestana-Knight; Judith L Weisenberg; Scott Demarest; Eric D Marsh; Heather E Olson
Journal:  CNS Drugs       Date:  2022-05-28       Impact factor: 6.497

Review 3.  Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting.

Authors:  Isabella Barbiero; Massimiliano Bianchi; Charlotte Kilstrup-Nielsen
Journal:  J Neuroendocrinol       Date:  2021-09-08       Impact factor: 3.870

4.  Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder.

Authors:  Joni N Saby; Patrick J Mulcahey; Alexis E Zavez; Sarika U Peters; Shannon M Standridge; Lindsay C Swanson; David N Lieberman; Heather E Olson; Alexandra P Key; Alan K Percy; Jeffrey L Neul; Charles A Nelson; Timothy P L Roberts; Timothy A Benke; Eric D Marsh
Journal:  Brain Commun       Date:  2022-08-04

Review 5.  CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

Authors:  Nicole J Van Bergen; Sean Massey; Anita Quigley; Ben Rollo; Alexander R Harris; Robert M I Kapsa; John Christodoulou
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

6.  Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency.

Authors:  Anna Adhikari; Fiona K B Buchanan; Timothy A Fenton; David L Cameron; Julian A N M Halmai; Nycole A Copping; Kyle D Fink; Jill L Silverman
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

7.  X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.

Authors:  Barbara Terzic; Yue Cui; Andrew C Edmondson; Sheng Tang; Nicolas Sarmiento; Daria Zaitseva; Eric D Marsh; Douglas A Coulter; Zhaolan Zhou
Journal:  Neurobiol Dis       Date:  2020-11-13       Impact factor: 5.996

8.  Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.

Authors:  Giuseppe Galvani; Nicola Mottolese; Laura Gennaccaro; Manuela Loi; Giorgio Medici; Marianna Tassinari; Claudia Fuchs; Elisabetta Ciani; Stefania Trazzi
Journal:  J Neuroinflammation       Date:  2021-07-08       Impact factor: 8.322

9.  Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy.

Authors:  Priscilla D Negraes; Cleber A Trujillo; Nam-Kyung Yu; Wei Wu; Hang Yao; Nicholas Liang; Jonathan D Lautz; Ellius Kwok; Daniel McClatchy; Jolene Diedrich; Salvador Martinez de Bartolome; Justin Truong; Ryan Szeto; Timothy Tran; Roberto H Herai; Stephen E P Smith; Gabriel G Haddad; John R Yates; Alysson R Muotri
Journal:  Mol Psychiatry       Date:  2021-04-22       Impact factor: 15.992

Review 10.  Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy.

Authors:  Wanqi Wang; Wayne N Frankel
Journal:  Neurobiol Dis       Date:  2020-12-07       Impact factor: 5.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.